Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Written By: Pharmacally Medical News Desk Sun Pharmaceutical Industries Limited has received approval from the Drug Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection for chronic weight management in adults
Role of gut hormones GLP-1 and PYY in appetite regulation in obesity
Benefits Features Common Uses How It Works FAQ Benefits Benefits When prescribed appropriately alongside lifestyle changes, Wegovy may help eligible patients with: Reduced appetite Improved feelings of fullness Support with calorie reduction Sustainable weight management Improvements in weight-related health outcomes Individual results vary, and treatment suitability should always be assessed by a healthcare professional
Adherence risk if doses are missed or not held under the tongue long enough
Efficacy and safety In clinical trials, individuals taking Ozempic have been shown to reduce 15-20 per cent of their body weight
US$ 29.87
US$ 28.14
US$ 28.17
